Oral UFT, etoposide and leucovorin in recurrent non-small cell lung cancer: A non-randomized phase II study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Oral UFT, etoposide and leucovorin in recurrent non-small cell lung cancer: A non-randomized phase II study

Published:2009-12 Issue:3 Volume:66 Page:333-337
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Surmont V.,Aerts J.G.,Pouw E.,Tan K.Y.,Vernhout R.,Gras J.,Salomé J.,Pronk T.,Schmitz P.I.M.,Hoogsteden H.,van Klaveren R.J.

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference39 articles.

1. Mitomycin, ifosfamide, and cisplatin in unresectable non-small-cell lung cancer: effects on survival and quality of life;Cullen;J Clin Oncol,1999

2. Randomized trial of paclitaxel plus best supportive care versus supportive care for patients with advanced non-small-cell lung cancer;Ranson;J Natl Cancer Inst,2000

3. Consensus conference on palliative treatment of stage IV non-small cell lung cancer. Consensus meeting of the Netherlands Society for Medical Oncology and the Taskforce on Lung Cancer of the Dutch Society of Physicians for Lung Diseases and Tuberculosis;Tjan-Heijnen;Neth J Med,2001

4. Is there a preferred combination chemotherapy regimen for metastastic non-small cell lung cancer?;Ettinger;Oncologist,2002

5. Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group;Fossella;J Clin Oncol,2000

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. De-escalating cancer treatments during COVID 19 pandemic: Is metronomic chemotherapy a reasonable option?;Critical Reviews in Oncology/Hematology;2021-01

2. Metronomic Chemotherapy: A Systematic Review of the Literature and Clinical Experience;Journal of Oncology;2019-03-20

3. Lung Cancer;Clinical Radiation Oncology;2017-05-05

4. Thymidylate synthase inhibitors for non-small cell lung cancer;Expert Opinion on Investigational Drugs;2011-09-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3